Absorption |
Blood-Brain Barrier | BBB+ | 0.9895 |
Human Intestinal Absorption | HIA+ | 0.9851 |
Caco-2 Permeability | Caco2+ | 0.7983 |
P-glycoprotein Substrate | Non-substrate | 0.7440 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9092 |
Non-inhibitor | 0.9241 |
Renal Organic Cation Transporter | Non-inhibitor | 0.9022 |
Distribution |
Subcellular localization | Mitochondria | 0.5086 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8506 |
CYP450 2D6 Substrate | Non-substrate | 0.8894 |
CYP450 3A4 Substrate | Non-substrate | 0.6345 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.6332 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9495 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9557 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9467 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9871 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9327 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9510 |
Non-inhibitor | 0.9371 |
AMES Toxicity | Non AMES toxic | 0.9604 |
Carcinogens | Carcinogens | 0.5680 |
Fish Toxicity | High FHMT | 0.5269 |
Tetrahymena Pyriformis Toxicity | Low TPT | 0.8366 |
Honey Bee Toxicity | High HBT | 0.7767 |
Biodegradation | Ready biodegradable | 0.9391 |
Acute Oral Toxicity | III | 0.8509 |
Carcinogenicity (Three-class) | Non-required | 0.6880 |